MIDA Mortality Risk (Degenerative MR Surgery) Calculator

Clinical calculation support · Verify results before clinical use

Patient and echocardiographic variables

Enter all seven variables. The score updates automatically using the published MIDA point assignments.

—Score / 12
3 points if age is 65 years or older.Enter an age from 18 to 120 years.
3 points when symptoms are present.Select whether NYHA II–IV symptoms are present.
1 point if present.Select an option.
1 point if LVEF is 60% or lower.Enter an LVEF greater than 0% and no more than 100%.
1 point if LVESD is 40 mm or greater.Enter an LVESD from 5 to 100 mm.
1 point if LA diameter is 55 mm or greater.Enter an LA diameter from 10 to 100 mm.
2 points if PASP is 50 mmHg or greater (confirm equivalence to the source variable in the clinical context).Enter a PASP from 0 to 200 mmHg.
—MIDA score
Score interpretation
Complete all fields
Enter the patient variables above to calculate the score (0–12).
Published post-surgical 1-year mortality anchors will be displayed when all fields are complete.

About the MIDA Mortality Risk Score

The MIDA Mortality Risk Score is a prognostic model developed and externally validated in patients with degenerative mitral regurgitation (DMR). It combines seven clinical and echocardiographic variables to describe mortality risk in the context of DMR management.

The total score ranges from 0 to 12. It is a prognostic aid, not an operative-risk calculator and not a stand-alone indication for surgery. The original registry primarily included patients with pure, isolated degenerative MR; secondary/functional MR and several other conditions were excluded.

Point assignment

VariableCriterionPoints
Age≥65 years3
SymptomsNYHA class II–IV3
Atrial fibrillationPresent1
LVEF≤60%1
LVESD≥40 mm1
LA diameter≥55 mm1
PASP / RV systolic pressure≥50 mmHg*2

Post-surgical 1-year mortality anchors

MIDA scoreReported mortality after surgery
0Approximately 1%
7–8Approximately 7%
11–12Approximately 14%

*The original publication describes right ventricular systolic pressure ≥50 mmHg. PASP is used here as the entered clinical estimate; confirm measurement and terminology locally. These are selected score-specific anchors from the original cohort, not a complete risk estimate for every score. Do not interpolate mortality percentages for other scores.

References

Grigioni F, Clavel M-A, Vanoverschelde J-L, et al.The MIDA Mortality Risk Score: development and external validation of a prognostic model for early and late death in degenerative mitral regurgitation. European Heart Journal. 2018;39(15):1281–1291. DOI: 10.1093/eurheartj/ehx465. PMID: 29020352.

Clinical use and limitations

  • Confirm that the clinical context is degenerative/primary MR and interpret the score with a complete clinical and echocardiographic assessment.
  • The score does not replace EuroSCORE II, STS, multidisciplinary Heart Team review, or current guideline-based decisions on intervention.
  • The published 1-year mortality anchors are specific to the cohort and treatment context reported in the original study.
Clinical disclaimer: This calculator supports clinical assessment and education. It must not be used as the sole basis for prognosis, surgical timing, or treatment decisions. Verify input measurements and apply current guideline recommendations, patient preferences, comorbidities, frailty, and multidisciplinary judgement.